FDA approves Ultragenyx's gene therapy for Sanfilippo syndrome type A

The FDA granted accelerated approval to a rare disease gene therapy from Ultragenyx on Thursday, giving the company a much-needed boost in an otherwise difficult year. The therapy, called UX111, will be branded as Fayuvi ...